Discovery explains how immune cells target DNA mutations to improve antibodies
Scientists at the Montreal Clinical Research Institute (IRCM), led by Université de Montréal medical professor Javier Di Noia, have shed light on a fundamental mystery in immunology: How do immune cells manage to concentrate a powerful mutagenic enzyme at precisely defined regions of DNA while largely sparing the rest of the genome from potentially dangerous damage?
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
More active teens report fewer sleep problems down the line, new study reveals
United Kingdom
-
Study across 8 European countries demonstrates feasibility of screening children for type 1 diabetes
United Kingdom
-
New weight-loss injection targets fat cells: CBL-514 selectively induces apoptosis of fat cells
United Kingdom
-
Pro-Trump Influencer Benny Johnson is being sued for defamation by ICE protesters
United States
-
Research finds sibling aggression to be common, though often dismissed as 'normal'
United Kingdom
-
Hunter-Gatherers Don’t Have Trouble Sleeping: Why? and What Can We Learn from Them?
United Kingdom
-
Childhood neglect may increase the risk of suicide attempts
United Kingdom
-
Tracing fetal DNA through maternal blood can help reduce prenatal testing errors
United Kingdom